The involvement of LL-37 has been reported in the pathogenesis of various disorders, including psoriasis, systemic lupus erythematosus, diabetes mellitus, rheumatoid arthritis, cardiovascular pathologies, and multiple types of cancer [29,30,31,32,33]. This evidence concerns the gene CAMP and systemic lupus erythematosus.